Outcome | Number of studies | Effect size and 95% interval | Test of null (2-Tail) | Heterogeneity | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Point estimate | Lower limit | Upper limit | Z-value | P-value | Q-value | df (Q) | P-value | I-squared | ||
SOD | 5 | 3.32 | 1.61 | 5.03 | 3.81 | < 0.001 | 29.47 | 4 | < 0.001 | 86.42 |
GPX | 5 | 4.50 | 0.30 | 8.70 | 2.10 | 0.036 | 102.65 | 4 | < 0.001 | 96.10 |
MDA | 8 | − 4.76 | − 8.68 | − 0.84 | − 2.38 | 0.017 | 176.87 | 7 | < 0.001 | 96.04 |
Caspase3 | 5 | − 11.45 | − 16.58 | − 6.33 | − 4.38 | < 0.001 | 100.85 | 4 | < 0.001 | 96.03 |
Plasma glucose | 12 | − 2.77 | − 3.77 | − 1.78 | − 5.50 | < 0.001 | 79.59 | 11 | < 0.001 | 86.18 |
Bcl-2 | 5 | 2.92 | − 0.93 | 6.77 | 1.48 | 0.138 | 77.49 | 4 | < 0.001 | 94.83 |
Bax | 5 | − 1.62 | − 6.78 | 3.53 | − 0.61 | 0.536 | 117.49 | 4 | < 0.001 | 96.59 |
Apoptosis index | 3 | − 6.53 | − 11.64 | − 1.41 | − 2.50 | 0.012 | 21.64 | 2 | < 0.001 | 90.76 |
Total cholesterol | 2 | − 7.56 | − 9.21 | − 5.91 | − 8.98 | < 0.001 | 0.037 | 1 | 0.848 | 0 |
Triglyceride (mg/dL) | 2 | − 3.40 | − 5.19 | − 1.62 | − 3.75 | < 0.001 | 3.71 | 1 | 0.054 | 73.06 |
HDL | 2 | 9.28 | − 1.35 | 19.92 | 1.71 | 0.087 | 25.84 | 1 | < 0.001 | 96.13 |
VLDL | 2 | − 6.92 | − 10.03 | − 3.82 | − 4.37 | < 0.001 | 4.00 | 1 | 0.045 | 75.05 |
VEGF | 5 | 3.69 | 1.83 | 5.55 | 3.89 | < 0.001 | 33.46 | 4 | < 0.001 | 88.04 |
IL-6 | 2 | − 1.26 | − 8.63 | 6.11 | − 0.33 | 0.738 | 36.98 | 1 | < 0.001 | 97.29 |
TNF-a | 2 | − 11.86 | − 15.05 | − 8.66 | − 7.27 | < 0.001 | 0.005 | 1 | 0.994 | 0 |
IL-1β (ng/ml) | 2 | − 5.20 | − 13.12 | 2.72 | − 1.28 | 0.198 | 19.69 | 1 | < 0.001 | 94.92 |
p53 | 4 | − 6.34 | − 13.74 | 1.04 | − 1.68 | 0.093 | 94.09 | 3 | < 0.001 | 96.81 |